MCAM and prostate cancer: As also shown in panels G-H, huMETCAM/MUC18 antigens were predominantly expressed on the cytoplasmic membrane, similar to the positive control tumor section from the prostate cancer cell line LNCaP-induced tumors (panel E in Figure 6b).